Gelmetix

📍 London, United Kingdom🗓 Founded 2012👥 9 employees💰 Last funded Sep 2018
Medical Device🌐 gelmetix.com
Website LinkedIn
Back pain is debilitating and limiting. It forces changes to the way people live and affects their quality of lie. Gelmetix addresses the most common cause of this critical problem through an efficient, cost effective and drug-free approach to preventing pain and restoring functionality and movement. Our patented polymer gel helps to restore the natural integrity of the disc itself. Injected directly, it rehydrates and stabilises, bringing back load-bearing properties and restoring the movement of the patient. Our polymer gel technology also has the potential to be adapted and extended for other uses. Gelmetix was founded in 2012, as a spin-off from the University of Manchester. In December 2020, Gelmetix was named “one of the most promising biotech start-ups in Europe” by EIT Health Catapult.
5
Total investors
0
Early stage
3
Mid stage
2
Late stage
2012
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United Kingdom
3
Guernsey
1
Investor activity2017–2018 · investors recorded per year
2017320182
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Gelmetix?
Gelmetix has 5 investors on record on gritt.io, 3 mid-stage and 2 late-stage investors.
When did Gelmetix last raise funding?
The most recent investment in Gelmetix recorded on gritt.io was in September 2018.
When was Gelmetix founded?
Gelmetix was founded in 2012.
What industry is Gelmetix in?
Gelmetix operates in Medical Device. Find similar Medical Device investors on gritt.io.
Where is Gelmetix based?
Gelmetix is headquartered in London, United Kingdom.